Conference Coverage: ESMO 2019 GU Highlights

Possible impact of recent select studies presented at ESMO on real-world clinical practice.

Daniel Petrylak, MD, Yale, Aptitude Health

Faculty Chair

Daniel Petrylak, MD

Yale Cancer Center, New Haven, CT, USA

Report includes strategic recommendations and key takeaways on:

    • Hormonal Approaches for Prostate Cancer
    • Castration-Resistant Prostate Cancer – Targeted and Immunotherapies
    • Updates in Renal Cell Carcinoma
    • Novel Agents for Urothelial/Bladder Cancers


Gerhardt Attard, MD, PhD
University College London, London, UK

Jorge A. García, MD
Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA

David Quinn, MD, PhD
University of Southern California, Los Angeles, CA, USA

Oliver Sartor, MD
Tulane University, New Orleans, LA, USA

Scott Tagawa, MD
Weill Cornell Medicine-Cornell University, New York, NY, USA

Explore Available and Upcoming Insight Reports

View Reports